Cargando…
Nitric Oxide (NO) and NO Synthases (NOS)-Based Targeted Therapy for Colon Cancer
Colorectal cancer (CRC) is one of the most lethal malignancies worldwide and CRC therapy remains unsatisfactory. In recent decades, nitric oxide (NO)—a free-radical gas—plus its endogenous producer NO synthases (NOS), have attracted considerable attention. NO exerts dual effects (pro- and anti-tumor...
Autores principales: | Wang, Hao, Wang, Liye, Xie, Zuoxu, Zhou, Shuang, Li, Yan, Zhou, Yue, Sun, Meiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408898/ https://www.ncbi.nlm.nih.gov/pubmed/32668616 http://dx.doi.org/10.3390/cancers12071881 |
Ejemplares similares
-
A Scallop Nitric Oxide Synthase (NOS) with Structure Similar to Neuronal NOS and Its Involvement in the Immune Defense
por: Jiang, Qiufen, et al.
Publicado: (2013) -
The expanding roles of neuronal nitric oxide synthase (NOS1)
por: Solanki, Kundan, et al.
Publicado: (2022) -
Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS)
por: Tong, Shirley, et al.
Publicado: (2022) -
Cannabinoid Regulation of Nitric Oxide Synthase I (nNOS) in Neuronal Cells
por: Carney, Skyla T., et al.
Publicado: (2009) -
Extensive Ethnogenomic Diversity of Endothelial Nitric Oxide Synthase (eNOS) Polymorphisms
por: Thomas, Bolaji N., et al.
Publicado: (2013)